Literature DB >> 23926167

Long-term carriage of vancomycin-resistant enterococci in patients discharged from hospitals: a 12-year retrospective cohort study.

Surendra Karki1, Gillian Land, Stacey Aitchison, Jacqueline Kennon, Paul D R Johnson, Susan A Ballard, Karin Leder, Allen C Cheng.   

Abstract

Contact precautions are recommended in hospitals to prevent the transmission of vancomycin-resistant enterococci (VRE); however, there is no clear policy for how long patients should be under contact precautions due to a lack of information on the duration of carriage of these organisms. We conducted a retrospective cohort study to understand the duration of carriage of VRE (by screening of a single stool culture) and associated factors among patients who had been identified with VRE infection and/or colonization since the year 2000 at our health facilities. Of the 345 eligible participants, 136 did not respond, 90 declined to participate, and 16 did not send in the required specimens. Of the 103 remaining participants, 13 were found to have current VRE fecal carriage. The proportion of colonized patients fell from 40% (2/5) in the first year to 23.3% (7/30) in year 4. None of the 40 patients who had VRE detected >4 years prior were found to be colonized at the time of the study. The longest duration of detected VRE positivity was 46.5 months. Univariate analysis revealed that recent exposure to any antibiotics (P = 0.016), multiple antibiotics (P = 0.001), amoxicillin-clavulanic acid (P = 0.021), piperacillin-tazobactam (P = 0.007), glycopeptides (P < 0.001), meropenem (P = 0.007), aminoglycosides (P = 0.021), or fluoroquinolones (P = 0.021), being the index case in a clinical specimen (P = 0.016), and recent hospitalization (P < 0.001) were significantly associated with continued carriage on follow-up. In the surviving outpatients, a significant proportion appeared to clear VRE carriage. Our results suggest that in the absence of recent risk factors, such as hospitalization or antibiotic use, patients with a remote history of colonization (>4 years) may no longer require contact isolation precautions.

Entities:  

Mesh:

Year:  2013        PMID: 23926167      PMCID: PMC3811615          DOI: 10.1128/JCM.01501-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci.

Authors:  Erika M C D'Agata; Shiva Gautam; William K Green; Yi-Wei Tang
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

2.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 3.  The epidemiology of fecal carriage of vancomycin-resistant enterococci.

Authors:  K K Lai; S A Fontecchio; A L Kelley; Z S Melvin; S Baker
Journal:  Infect Control Hosp Epidemiol       Date:  1997-11       Impact factor: 3.254

4.  Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients.

Authors:  R Patel; S L Allen; J M Manahan; A J Wright; R A Krom; R H Wiesner; D H Persing; F R Cockerill; R L Thompson
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

5.  Recurrent vancomycin-resistant Enterococcus bacteremia: prevalence, predisposing factors, and strain relatedness.

Authors:  J Baran; K M Riederer; J Ramanathan; R Khatib
Journal:  Clin Infect Dis       Date:  2001-04-09       Impact factor: 9.079

6.  Duration of colonization with vancomycin-resistant Enterococcus.

Authors:  Karin E Byers; Anne M Anglim; Cynthia J Anneski; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2002-04       Impact factor: 3.254

7.  Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance".

Authors:  L R Baden; W Thiemke; A Skolnik; R Chambers; J Strymish; H S Gold; R C Moellering; G M Eliopoulos
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

8.  Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.

Authors:  K J Henning; H Delencastre; J Eagan; N Boone; A Brown; M Chung; N Wollner; D Armstrong
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

9.  Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Authors:  Nereo Segnan; Carlo Senore; Bruno Andreoni; Arrigo Arrigoni; Luigi Bisanti; Alessandro Cardelli; Guido Castiglione; Cristiano Crosta; Roberta DiPlacido; Arnaldo Ferrari; Roberto Ferraris; Franco Ferrero; Mario Fracchia; Stefano Gasperoni; Giuseppe Malfitana; Serafino Recchia; Mauro Risio; Mario Rizzetto; Giorgio Saracco; Mauro Spandre; Delio Turco; Patricia Turco; Marco Zappa
Journal:  J Natl Cancer Inst       Date:  2005-03-02       Impact factor: 13.506

10.  Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.

Authors:  Kyung Mok Sohn; Kyong Ran Peck; Eun-Jeong Joo; Young Eun Ha; Cheol-In Kang; Doo Ryeon Chung; Nam Yong Lee; Jae-Hoon Song
Journal:  Int J Infect Dis       Date:  2012-11-26       Impact factor: 3.623

View more
  12 in total

1.  Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort study.

Authors:  Ian Brasg; Marion Elligsen; Derek MacFadden; Nick Daneman
Journal:  CMAJ Open       Date:  2017-08-15

Review 2.  Resistance in Vancomycin-Resistant Enterococci.

Authors:  William R Miller; Barbara E Murray; Louis B Rice; Cesar A Arias
Journal:  Infect Dis Clin North Am       Date:  2020-12       Impact factor: 5.982

3.  Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.

Authors:  P Zachariah; D E Freedberg
Journal:  J Hosp Infect       Date:  2019-01-11       Impact factor: 3.926

4.  Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.

Authors:  Isaac See; Alison G Freifeld; Shelley S Magill
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

5.  A multicentre hospital outbreak in Sweden caused by introduction of a vanB2 transposon into a stably maintained pRUM-plasmid in an Enterococcus faecium ST192 clone.

Authors:  Audun Sivertsen; Hanna Billström; Öjar Melefors; Barbro Olsson Liljequist; Karin Tegmark Wisell; Måns Ullberg; Volkan Özenci; Arnfinn Sundsfjord; Kristin Hegstad
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

6.  Hospital acquired vancomycin resistant enterococci in surgical intensive care patients - a prospective longitudinal study.

Authors:  Stefanie Kampmeier; Annelene Kossow; Larissa Monika Clausen; Dennis Knaack; Christian Ertmer; Antje Gottschalk; Hendrik Freise; Alexander Mellmann
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-23       Impact factor: 4.887

7.  Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland.

Authors:  Kimon Lemonidis; Talal S Salih; Stephanie J Dancer; Iain S Hunter; Nicholas P Tucker
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

8.  A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland.

Authors:  Kathy E Raven; Sandra Reuter; Rosy Reynolds; Hayley J Brodrick; Julie E Russell; M Estée Török; Julian Parkhill; Sharon J Peacock
Journal:  Genome Res       Date:  2016-08-15       Impact factor: 9.043

9.  Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone.

Authors:  Andrew A Mahony; Andrew H Buultjens; Susan A Ballard; Elizabeth A Grabsch; Shirley Xie; Torsten Seemann; Rhonda L Stuart; Despina Kotsanas; Allen Cheng; Helen Heffernan; Sally A Roberts; Geoffrey W Coombs; Narin Bak; John K Ferguson; Glen C Carter; Benjamin P Howden; Timothy P Stinear; Paul D R Johnson
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-22       Impact factor: 4.887

10.  Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.

Authors:  Agnes Loo Yee Cheah; Allen C Cheng; Denis Spelman; Roger L Nation; David C M Kong; Emma S McBryde
Journal:  BMC Infect Dis       Date:  2018-10-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.